Finland· FI-REL-REL41598
Ziprasidon Krka
A ziprasidone product containing ziprasidone hydrogensulphate, registered in Finland by KRKA d.d. Novo mesto. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ziprasidone is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AE04 (ziprasidone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Ziprasidone · ATC N05AE04
14 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ziprasidone costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ziprasidone · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.54 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Ziprasidone hydrogensulphate
- Manufacturer
- KRKA d.d. Novo mesto
- Country
- Finland (FI)
- ATC code
- N05AE04
- ATC class
- Ziprasidone
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa068599100EUR 165.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
403 interactions on record for ziprasidone.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ziprasidone · interactions on record
403 records
- 147 severe
- 162 moderate
- 38 minor
- 56 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ziprasidone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGeodonViatris Specialty LLC
- SpainZELDOX 60 mg CAPSULAS DURASViatris Healthcare Limited
- SwedenZeldox 60 mg Kapsel, hårdViatris Healthcare Limited
- CzechiaZELDOXUpjohn EESV, Capelle aan den IJssel
- IrelandGeodon 60mg capsules, hardUpjohn EESV
- CanadaAURO-ZIPRASIDONEAURO PHARMA INC
- IcelandZeldoxViatris ApS
- PolandZypsilaKrka, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Zeldox, Ziprasidon Krka
- Bulgaria · Зелдокс, Зипсила
- Cyprus · Geodon
- Czechia · Zeldox, Zypsilan
- Germany · Zeldox, Ziprasidon 1 A Pharma
- Denmark · Zeldox, Ziprasidon Krka
- Spain · Zeldox, Ziprasidona Aurovitas
- Greece · Geodon, Ziprasidone Actavis
- Croatia · Zeldox
- Hungary · Ypsila, Zeldox
- Ireland · Geodon
- Iceland · Zeldox, Ziprasidon Actavis
- Italy · Zeldox, Ziprasidone Sandoz
- Lithuania · Zeldox, Zypsilan
- Latvia · Ypsila, Zeldox
- Malta · Ziprasidone Aurobindo
- Norway · Zeldox, Ziprasidon Actavis
- Poland · Zypsila
- Portugal · Zeldox, Ziprasidona Aurobindo
- Romania · Zypsila
- Sweden · Zeldox, Ziprasidon Actavis
- Slovenia · Zeldox, Zypsila
- Slovakia · Zeldox, Zipwell
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa9e9e69-77b2-40e2-a385-33d66bd7175c GET /v1/drugs/fa9e9e69-77b2-40e2-a385-33d66bd7175c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "80",
"form": "kapseli, kova",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "60 mg",
"atc_label": "tsiprasidoni",
"ma_number": "30565",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL41598",
"authorised_at": "2012-07-26"
}See everything about ziprasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.